Europe Contrast Media Market Size & Share Report 2019-2025

Europe Contrast Media Market By Product Type (Iodinated, Barium-based, Gadolinium-based and Microbubble) By Application (Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications) By Modality (X-ray/CT, MRI and Ultrasound) By Country, Industry Analysis and Forecast, 2019 - 2025

Published Date: March-2020 | Number of Pages: 95 | Format: PDF | Report ID: KBV-12841

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Contrast Media Market, by Product Type
1.4.2 Europe Contrast Media Market, by Application
1.4.3 Europe Contrast Media Market, by Modality
1.4.4 Europe Contrast Media Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019–Mar, 2015) Leading Players

Chapter 4. Europe Contrast Media Market by Product Type
4.1 Europe Iodinated Market by Country
4.2 Europe Barium-based Market by Country
4.3 Europe Gadolinium-based Market by Country
4.4 Europe Microbubble Market by Country

Chapter 5. Europe Contrast Media Market by Application
5.1 Europe Neurological disorders Market by Country
5.2 Europe Cancer Market by Country
5.3 Europe Cardiovascular disorders Market by Country
5.4 Europe Gastrointestinal disorders Market by Country
5.5 Europe Nephrological disorders Market by Country
5.6 Europe Musculoskeletal disorders Market by Country
5.7 Europe Other Applications Market by Country

Chapter 6. Europe Contrast Media Market by Modality
6.1 Europe X-ray/CT Market by Country
6.2 Europe MRI Market by Country
6.3 Europe Ultrasound Market by Country

Chapter 7. Europe Contrast Media Market by Country
7.1 Germany Contrast Media Market
7.1.1 Germany Contrast Media Market by Product Type
7.1.2 Germany Contrast Media Market by Application
7.1.3 Germany Contrast Media Market by Modality
7.2 UK Contrast Media Market
7.2.1 UK Contrast Media Market by Product Type
7.2.2 UK Contrast Media Market by Application
7.2.3 UK Contrast Media Market by Modality
7.3 France Contrast Media Market
7.3.1 France Contrast Media Market by Product Type
7.3.2 France Contrast Media Market by Application
7.3.3 France Contrast Media Market by Modality
7.4 Russia Contrast Media Market
7.4.1 Russia Contrast Media Market by Product Type
7.4.2 Russia Contrast Media Market by Application
7.4.3 Russia Contrast Media Market by Modality
7.5 Spain Contrast Media Market
7.5.1 Spain Contrast Media Market by Product Type
7.5.2 Spain Contrast Media Market by Application
7.5.3 Spain Contrast Media Market by Modality
7.6 Italy Contrast Media Market
7.6.1 Italy Contrast Media Market by Product Type
7.6.2 Italy Contrast Media Market by Application
7.6.3 Italy Contrast Media Market by Modality
7.7 Rest of Europe Contrast Media Market
7.7.1 Rest of Europe Contrast Media Market by Product Type
7.7.2 Rest of Europe Contrast Media Market by Application
7.7.3 Rest of Europe Contrast Media Market by Modality

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities